EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antiviral mechanism of glycyrrhizic acid against BVDV: suppression of viral replication and immune regulation

Yunnan Fang, Youli Yu, Zhengqing Yu, Jiandong Wang, Zhengwei Zhao, Yanan Guo, Yuxi Zhao, Dongdong Cai, Yuqiu Yang, Pan Zhou

Frontiers in Microbiology · 29.10.2026 · 17

DOI: 10.3389/fmicb.2026.1924475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 29.10.2026. Verfasst von Yunnan Fang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Animal Science and Technology, Ningxia University, Yinchuan, Ningxia, China. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Bovine viral diarrhea virus (BVDV), a globally prevalent pathogen in cattle, causes severe economic losses through acute diarrhea, immunosuppression, and reproductive failure, with mortality rates reaching 20%–30% in persistently infected herds. This study investigated glycyrrhizic acid (GA), a bioactive triterpenoid glycoside derived from licorice root with known anti-inflammatory and broad-spectrum antiviral properties, as a potential inhibitor of BVDV replication.

Methods

Using in vitro (MDBK cells) and in vivo (BALB/c mice) models, we evaluated the antiviral and immunomodulatory effects of GA. Cells were treated with 10 μM GA, and mice received 20 mg/kg/day GA. Viral replication, cytokine expression, hepatic histopathology, and gut microbiota were assessed.

Results

GA treatment significantly reduced BVDV replication, decreasing 5’UTR and NS5B mRNA expression by >80% ( P < 0.01) and viral titers by 2.3-log in liver tissue. GA concurrently modulated host immune responses, suppressing pro-inflammatory cytokines (TNF-α by 68%, IL-6 by 54%) while elevating IL-10 (2.1-fold), and substantially improved hepatic histopathology scores ( P < 0.05 versus infected controls). ELISA revealed GA-mediated downregulation of IFN-β during infection. Analysis of gut microbiota at 7 days post-infection revealed that both GA and ribavirin (RBV) treatments modulated microbial community structure, with RBV showing profiles more closely resembling uninfected controls.

Discussion

These findings establish GA’s dual antiviral mechanism—direct suppression of viral RNA synthesis and immunomodulation—positioning this natural compound as a promising therapeutic candidate against BVDV infection in livestock.

Schlagwörter

Stichwörter der Autor:innen

anti-infection researchbovine viral diarrhea virusglycyrrhizic acidgut microbiotamouse model

Autor:innen und Institutionen

  • Animal Science and Technology, Ningxia University, Yinchuan, Ningxia, China.
  • Institute of Animal Science, Ningxia Academy of Agricultural and Forestry Science, Yinchuan, China.
  • Animal Disease Control Center of Yanchi County, Yanchi, China.

Zitieren

APA

Fang, Y., Yu, Y., Yu, Z., Wang, J., Zhao, Z., Guo, Y., Zhao, Y., Cai, D., Yang, Y., & Zhou, P. (2026). Antiviral mechanism of glycyrrhizic acid against BVDV: suppression of viral replication and immune regulation. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1924475

Vancouver

Fang Y, Yu Y, Yu Z, Wang J, Zhao Z, Guo Y, et al. Antiviral mechanism of glycyrrhizic acid against BVDV: suppression of viral replication and immune regulation. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1924475

BibTeX
@article{Fang2026,
  author = {Fang, Yunnan and Yu, Youli and Yu, Zhengqing and Wang, Jiandong and Zhao, Zhengwei and Guo, Yanan and Zhao, Yuxi and Cai, Dongdong and Yang, Yuqiu and Zhou, Pan},
  title = {Antiviral mechanism of glycyrrhizic acid against BVDV: suppression of viral replication and immune regulation},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1924475}
}
Kostenlos starten →